These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 17112728)

  • 1. Does preserving memory correlate with surviving HIV?
    Horton H; De Rosa SC
    Trends Microbiol; 2007 Jan; 15(1):1-3. PubMed ID: 17112728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine improves survival in monkey tests.
    James JS
    AIDS Treat News; 2006; (418):4. PubMed ID: 16886259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.
    Monceaux V; Viollet L; Petit F; Cumont MC; Kaufmann GR; Aubertin AM; Hurtrel B; Silvestri G; Estaquier J
    J Virol; 2007 Dec; 81(24):13865-75. PubMed ID: 17898067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
    Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
    AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low pre-infection levels and loss of central memory CD4+ T cells may predict rapid progression in SIV-infected pigtail macaques.
    Mason RD; Rose RD; Seddiki N; Kelleher AD; Kent SJ
    Virology; 2008 Nov; 381(1):11-5. PubMed ID: 18835006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy.
    Verhoeven D; Sankaran S; Dandekar S
    J Med Primatol; 2007 Aug; 36(4-5):219-27. PubMed ID: 17669210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity in natural SIV infections.
    Silvestri G
    J Intern Med; 2009 Jan; 265(1):97-109. PubMed ID: 19093963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease.
    Peut V; Kent SJ
    Virology; 2009 Feb; 384(1):21-7. PubMed ID: 19091370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's the matter with HIV-directed killer T cells?
    Wick D; Self SG
    J Theor Biol; 2002 Nov; 219(1):19-31. PubMed ID: 12392972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.
    Schulte R; Suh YS; Sauermann U; Ochieng W; Sopper S; Kim KS; Ahn SS; Park KS; Stolte-Leeb N; Hunsmann G; Sung YC; Stahl-Hennig C
    Virology; 2009 Jan; 383(2):300-9. PubMed ID: 19027133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
    Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Pavone-Cossut MR; Macchia I; Farcomeni S; Tenner-Racz K; Racz P; Ensoli B; Titti F
    J Med Primatol; 2007 Aug; 36(4-5):180-94. PubMed ID: 17669207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine advance: monkeys still infected, but protected from illness.
    James JS
    AIDS Treat News; 2000 Oct; (353):2-3. PubMed ID: 12173554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human and nonhuman primate lentiviral infection and autoimmunity.
    Onlamoon N; Pattanapanyasat K; Ansari AA
    Ann N Y Acad Sci; 2005 Jun; 1050():397-409. PubMed ID: 16014557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Containing HIV after infection.
    Walker BD; Rosenberg ES
    Nat Med; 2000 Oct; 6(10):1094-5. PubMed ID: 11017132
    [No Abstract]   [Full Text] [Related]  

  • 19. Radical approach to HIV vaccine.
    Nurs Stand; 1992 Sep 30-Oct 6; 7(2):17. PubMed ID: 1419714
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS research turned upside down.
    Maddox J
    Nature; 1991 Sep; 353(6342):297. PubMed ID: 1922331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.